The global lung stent market size was estimated to be USD 194.9 million in 2023 and is expected to reach at USD 433.1 million by 2034 with a CAGR of 7.53% during the forecast period 2024-2034. The rise in the prevalence of diseases such as lung cancer, escalating prevalence of respiratory conditions such as COPD (chronic obstructive pulmonary disease) & asthma, growing research & development initiatives, heightened investments by key industry players, rising preference for minimally invasive procedures, a surge in number of surgical interventions, advancements in stent technology, an increasing elderly population susceptible to respiratory disorders, a growing emphasis on bioresorbable stent development, and increasing approval of innovative lung stent products are contributing factors boosting the market growth.
Increasing approval of innovative lung stent products is predicted to boost the market growth during the forecast period. An endobronchial prosthesis made of various materials that maintains and sustains the patency of the empty tubular airway structure is known as an airway or lung stent. Due to advantages such as a quicker recovery period, a lower risk of problems, and increased patient comfort, lung stents are becoming more and more popular. By maintaining airway patency and improving airflow, lung stents provide less intrusive treatments. Therefore, the endorsement of such products contributes significantly more to the growth of the market. For instance, in July 2023, The Cordis Palmaz Mullins XD Pulmonary Stent has received FDA approval for use in treating pulmonary artery stenosis (PAS) in pediatric patients.
By type, tracheobronchial stents was the highest revenue-grossing segment in the global lung stent market in 2023 owing to the increasing use of tracheal stents in the treatment of large airways and non-malignant diseases, as well as the increasing acceptance of bronchial and tracheal stents for the treatment of respiratory disorders because of their availability in a range of sizes, shapes, and materials and the lower risk of surgical complications after stent implantation. Additionally, laryngeal stents is predicted to grow at the fastest CAGR during the forecast period owing to the increasing launch of new products. Laryngotracheal reconstructive surgery sometimes requires the implantation of a laryngeal stent. Laryngeal stents are solid or flat tubes with a range of diameters, shapes, and textures. They can be formed of different materials. Stents are used to support laryngeal or tracheal reconstructive efforts to stop lumen collapse, or as the initial therapy for the condition. Laryngeal stents are used to treat laryngeal fractures, laryngeal stenosis, and subglottic stenosis. They provide smooth, strong, conforming support. The specific hardness of laryngeal stent material allows for tissue support without causing harm to it. They adhere to the inside shape of the larynx and are compressible and flexible. For instance, in April 2022, Shanghai MicroPort Endovascular MedTech, Ltd organized a product launch event called "Elephant trunk for the heart: revival of the classic" to introduce its Fontus Branched Surgical Stent Graft System (Fontus).
By material, silicon stents was the highest revenue-grossing segment in the global lung stent market in 2023 owing to the expanding research and development efforts in the field of silicon stents, rising incidence of lung and respiratory disorders. For instance, in April 2023, As per the NCBI-published article, a recent meta-analysis investigated the effectiveness of silicone stents in addressing benign airway obstructions. The comprehensive assessment, which integrated data from eight studies involving 395 patients, showcased favorable outcomes for silicone stents. These findings emphasize that silicone stents represent a viable and effective long-term treatment option for benign airway obstructions Additionally, metal stents is predicted to grow at the fastest CAGR during the forecast period. This is because metal stents are superior to plastic stents in two ways: first, they do not block side branches; and second, since many hilar tumors are spherical and solid, tumor ingrowth appears to be less prevalent. A longer but still limited lifespan of 4-6 months is provided with metallic stents.
By product, self-expandable stents was the highest revenue-grossing segment in the global lung stent market in 2023 due to their dependable support, convenient deployment, compact size, and reduced risk of stent-related complications, surgeons are increasingly favoring expandable stents over non-expandable ones and rising introduction of new products. For instance, in February 2022, Micro-Tech Endoscopy has unveiled the initial self-expanding nitinol Y-shaped stent for the tracheobronchial region. This Tracheal Stent System with a Y-shaped design is crafted as a flexible, adaptable device intended for assisting in the treatment of malignant neoplasms located at the tracheobronchial carina. Additionally, non-expandable stents is predicted to grow at the fastest CAGR during the forecast period owing to the increasing technological advancements and surge in the approval of innovative products.
By end-user, hospital was the highest revenue-grossing segment in the global lung stent market in 2023 owing to the increased availability of improved pulmonology facilities with prompt diagnosis, surge in respiratory treatments as a result of easy access to the most advanced facilities & equipment, growing cost of treating lung diseases, and a rise in market player mergers and acquisitions. For instance, in August 2023, The U.S.-based medical implant manufacturer, Theken Companies, has completed the acquisition of VisionAir Solutions, a spinout company focused on Cleveland Clinic-developed technologies. The primary technology of VisionAir produces anatomically-specific 3D-printed airway stents for each patient. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to a shorter length of stay is provided after surgery in ambulatory surgical facilities, which are more affordable than traditional hospitals. The need for pulmonary stents is also being driven by an increase in the number of ambulatory surgery clinics and a growth in the popularity of minimally invasive procedures.
North America region is anticipated for the highest revenue share during the forecast period owing to the increased number of patients being admitted to hospitals for respiratory conditionsThe existence of large manufacturers, the growing emphasis of major businesses on offering efficient treatment alternatives, and the elevated awareness among surgeons regarding the use of sophisticated stents. For instance, in July 2022, Micro-Tech Co. Ltd, a company specializing in diagnostic and therapeutic devices, revealed a collaboration with Thoracent, Inc., a pioneer in pulmonary and thoracic products. Under this partnership, Thoracent, Inc. will serve as the distributor for Micro-tech's Y-shaped Tracheal Stent System in the United States. This system is specifically crafted to assist in the treatment of airway tumors in the trachea without the need for invasive surgical procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing the expanding initiatives by government and non-government organizations, growing R&D efforts, rising stent technology developments, increasing respiratory disease prevalence, and growing market player mergers and acquisitions. For instance, in June 2022, Boston Scientific has entered into a firm agreement with Synergy Innovation to purchase approximately 64% of its majority stake in M.I.Tech, a Korean company specializing in the production of gastrointestinal and airway stents, in a deal valued at USD 230 million.
Increasing approval of innovative lung stent products is predicted to boost the market growth during the forecast period. An endobronchial prosthesis made of various materials that maintains and sustains the patency of the empty tubular airway structure is known as an airway or lung stent. Due to advantages such as a quicker recovery period, a lower risk of problems, and increased patient comfort, lung stents are becoming more and more popular. By maintaining airway patency and improving airflow, lung stents provide less intrusive treatments. Therefore, the endorsement of such products contributes significantly more to the growth of the market. For instance, in July 2023, The Cordis Palmaz Mullins XD Pulmonary Stent has received FDA approval for use in treating pulmonary artery stenosis (PAS) in pediatric patients.
By type, tracheobronchial stents was the highest revenue-grossing segment in the global lung stent market in 2023 owing to the increasing use of tracheal stents in the treatment of large airways and non-malignant diseases, as well as the increasing acceptance of bronchial and tracheal stents for the treatment of respiratory disorders because of their availability in a range of sizes, shapes, and materials and the lower risk of surgical complications after stent implantation. Additionally, laryngeal stents is predicted to grow at the fastest CAGR during the forecast period owing to the increasing launch of new products. Laryngotracheal reconstructive surgery sometimes requires the implantation of a laryngeal stent. Laryngeal stents are solid or flat tubes with a range of diameters, shapes, and textures. They can be formed of different materials. Stents are used to support laryngeal or tracheal reconstructive efforts to stop lumen collapse, or as the initial therapy for the condition. Laryngeal stents are used to treat laryngeal fractures, laryngeal stenosis, and subglottic stenosis. They provide smooth, strong, conforming support. The specific hardness of laryngeal stent material allows for tissue support without causing harm to it. They adhere to the inside shape of the larynx and are compressible and flexible. For instance, in April 2022, Shanghai MicroPort Endovascular MedTech, Ltd organized a product launch event called "Elephant trunk for the heart: revival of the classic" to introduce its Fontus Branched Surgical Stent Graft System (Fontus).
By material, silicon stents was the highest revenue-grossing segment in the global lung stent market in 2023 owing to the expanding research and development efforts in the field of silicon stents, rising incidence of lung and respiratory disorders. For instance, in April 2023, As per the NCBI-published article, a recent meta-analysis investigated the effectiveness of silicone stents in addressing benign airway obstructions. The comprehensive assessment, which integrated data from eight studies involving 395 patients, showcased favorable outcomes for silicone stents. These findings emphasize that silicone stents represent a viable and effective long-term treatment option for benign airway obstructions Additionally, metal stents is predicted to grow at the fastest CAGR during the forecast period. This is because metal stents are superior to plastic stents in two ways: first, they do not block side branches; and second, since many hilar tumors are spherical and solid, tumor ingrowth appears to be less prevalent. A longer but still limited lifespan of 4-6 months is provided with metallic stents.
By product, self-expandable stents was the highest revenue-grossing segment in the global lung stent market in 2023 due to their dependable support, convenient deployment, compact size, and reduced risk of stent-related complications, surgeons are increasingly favoring expandable stents over non-expandable ones and rising introduction of new products. For instance, in February 2022, Micro-Tech Endoscopy has unveiled the initial self-expanding nitinol Y-shaped stent for the tracheobronchial region. This Tracheal Stent System with a Y-shaped design is crafted as a flexible, adaptable device intended for assisting in the treatment of malignant neoplasms located at the tracheobronchial carina. Additionally, non-expandable stents is predicted to grow at the fastest CAGR during the forecast period owing to the increasing technological advancements and surge in the approval of innovative products.
By end-user, hospital was the highest revenue-grossing segment in the global lung stent market in 2023 owing to the increased availability of improved pulmonology facilities with prompt diagnosis, surge in respiratory treatments as a result of easy access to the most advanced facilities & equipment, growing cost of treating lung diseases, and a rise in market player mergers and acquisitions. For instance, in August 2023, The U.S.-based medical implant manufacturer, Theken Companies, has completed the acquisition of VisionAir Solutions, a spinout company focused on Cleveland Clinic-developed technologies. The primary technology of VisionAir produces anatomically-specific 3D-printed airway stents for each patient. Additionally, ambulatory surgical centers is predicted to grow at the fastest CAGR during the forecast period owing to a shorter length of stay is provided after surgery in ambulatory surgical facilities, which are more affordable than traditional hospitals. The need for pulmonary stents is also being driven by an increase in the number of ambulatory surgery clinics and a growth in the popularity of minimally invasive procedures.
North America region is anticipated for the highest revenue share during the forecast period owing to the increased number of patients being admitted to hospitals for respiratory conditionsThe existence of large manufacturers, the growing emphasis of major businesses on offering efficient treatment alternatives, and the elevated awareness among surgeons regarding the use of sophisticated stents. For instance, in July 2022, Micro-Tech Co. Ltd, a company specializing in diagnostic and therapeutic devices, revealed a collaboration with Thoracent, Inc., a pioneer in pulmonary and thoracic products. Under this partnership, Thoracent, Inc. will serve as the distributor for Micro-tech's Y-shaped Tracheal Stent System in the United States. This system is specifically crafted to assist in the treatment of airway tumors in the trachea without the need for invasive surgical procedures. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing the expanding initiatives by government and non-government organizations, growing R&D efforts, rising stent technology developments, increasing respiratory disease prevalence, and growing market player mergers and acquisitions. For instance, in June 2022, Boston Scientific has entered into a firm agreement with Synergy Innovation to purchase approximately 64% of its majority stake in M.I.Tech, a Korean company specializing in the production of gastrointestinal and airway stents, in a deal valued at USD 230 million.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
Study Coverage
- Market Forecast by Type, Material, Product, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Lung Stent Market Report 2023 - 2034
Lung Stent Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Mn)
- Laryngeal Stents
- Tracheobronchial Stents
Lung Stent Market Analysis & Forecast by Material 2023 - 2034 (Revenue USD Mn)
- Hybrid Stents
- Silicon Stents
- Metal Stents
- Stainless Steel Stents
- Nitinol Stents
- Other Metal Stents
- Others
Lung Stent Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Mn)
- Non-expandable Stents
- Self-expandable Stents
Lung Stent Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Ambulatory Surgical Centers
- Hospitals
Lung Stent Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Lung Stent Market: Type Estimates & Trend Analysis
8. Lung Stent Market: Material Estimates & Trend Analysis
9. Lung Stent Market: Product Estimates & Trend Analysis
10. Lung Stent Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Lung Stent Market
13. Europe Lung Stent Market
14. Asia Pacific Lung Stent Market
15. Latin America Lung Stent Market
16. MEA Lung Stent Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Micro-Tech (Nanjing) Co. Ltd.
- Novatech SA
- Boston Scientific Corporation
- IncStening SRL
- Merit Medical Systems
- Cook Medical
- ENDO-FLEX GmbH.
- Taewoong Medical Co. Ltd.
- Cook Group
- E. Benson Hood Laboratories Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 194.9 Million |
| Forecasted Market Value ( USD | $ 433.1 Million |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
